Caxton Associates LP Personalis, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.78 - $3.64 $109,772 - $224,478	-61,670 Reduced 71.55%	24,524 $48,000
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $126,636 - $233,117	43,819 Added 103.41%	86,194 $256,000
Q2 2022 Aug 15, 2022	BUY	$3.27 - $8.76 $29,799 - $79,829	9,113 Added 27.4%	42,375 $146,000
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $251,460 - $475,646	33,262 New	33,262 $272,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $180M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.